Nov 25, 2025 12:00 PM Eastern Standard Time This expanded agreement provides Vasomune with increased financial support and the ability to pursue more development opportunities to mitigate pathological vascular leakage. About Vasomune Therapeutics, Inc. Vasomune Therapeutics, Inc. is a private clinical-stage biopharmaceutical company developing the next generation of medicines to boost the body's ability to defend against vascular leak. Founded in 2014, Vasomune has focused on vascular normalization strategi ...